arrow_rightarrow_righticon_excelicon_pficon_ppticon_wordmagnifier

SATURDAY 9 OCTOBER 2021

Saturday 09 Oct

Plenary Session 2 The great wall of Fungi

Chairs: Carol Munro, United Kingdom & Julian Naglik, United Kingdom

08:30

PS2.1 Immune recognition of fungi: the writing on the wall

Neil Gow, United Kingdom, FECMM

09:00

PS2.2 Aspergillus fumigatus cell wall

Isabel Valsecchi, France

09:30

Top 10 Papers: Clinical / diagnostics / treatment

Don Sheppard, Canada, FECMM & Katrien Lagrou, Belgium, FECMM

09:45

Top 10 Papers: Basic / immunology / genomics

Julian Naglik, United Kingdom & Agostinho Carvalho, Portugal, FECMM

10:00

Coffee break

Quiz the expert sessions

10:15

Q01 PCR based diagnosis of invasive mold infection

Maurizio Sanguinetti, Italy & Sean Zhang , USA

10:15

Q02 Recurrent Vulvovaginal Candidiasis (RVVC) - A diagnostic challenge

Riina Richardson, United Kingdom, FECMM

10:15

Q03 Clinical Mycology- How to get things going in LMICs

Rita Oladele, Nigeria, FECMM & Bright Ocansey, Ghana

10:15

Q04 Management of candida in the ICU

Luis Ostrosky-Zeichner, USA, FECMM & Patricia Muñoz, Spain

10:15

Q05 Beta d glucan in paediatrics

Laura Ferreras-Antolin, United Kingdom & Thomas Lehrnbecher, Germany

10:15

Q06 Teaching Medical Mycology

Ester Segal, Israel, FECMM & June Kwon-Chung, USA

11:00

Poster session

12:00

Lunch break

12:30

Sponsored Integrated Symposium 2

More information on https://www.timm2021.org/sponsored-symposia/

14:15

Parallel Symposia 5-9

Symposium 5 Dermatophytes and fungal skin infections

Chairs: Sevtap Arikan Akdagli, Turkey, FECMM & Arunaloke Chakrabarti, India, FECMM

14:15

S05.1 Global epidemiology: What is changing, what is remarkable?

Rudramurthy Shivaprakash, India, FECMM

14:35

S05.2 How to determine MICs for my dermatophyte strain: Protocoles, tips, and trics

Sevtap Arikan Akdagli, Turkey, FECMM

14:55

S05.3 Primary immunodeficiencies and dermatophytoses: What else do we know?

Fanny Lanternier, France, FECMM

15:15

S05.4 Malassezia: epidemiology and host-response studies’

Dora Corzo-Leon, Scotland, United Kingdom

15:35

S05.5 Evaluation of the multiplex real-time PCR DermaGenius® assay for the detection of dermatophytes in hair samples from Senegal

Mouhamadou Ndiaye, Senegal

Symposium 6 Immunity to fungi

Chairs: Agostinho Carvalho, Portugal, FECMM & Rebecca Drummond, United Kingdom

14:15

S06.1 How do Antibiotics Promote Susceptibility to Healthcare-Associated Fungal Infections?

Rebecca Drummond, United Kingdom

14:35

S06.2 Human genetic determinism of fungal diseases

Anna Puel, France

14:55

S06.3 Immunity to fungi in pneumocystis

Jay K Kolls, USA

15:15

S06.4 Serum proteins, crucial factors for human physiology that are exploited by Candida species to promote pathogenicity

Mark Gresnigt, Germany

15:30

S06.5 Increased efficacy of IL-18/posaconazole combination in a neutropenic animal model of pulmonary invasive aspergillosis by an azole resistant A.fumigatus isolate

Panagiota-Christina Georgiou, Greece

Symposium 7 Prophylaxis of Invasive Fungal Infections in Solid Organ Transplant Recipients

Chairs: Shahid Husain, Canada, FECMM & Patricia Muñoz, Spain

14:15

S07.1 Alternatives to drug treatment

Mihai Netea, the Netherlands

14:35

S07.2 Antifungal prophylaxis: Who, with what and how long?

Shmuel Shoham, USA

14:55

S07.3 Epidemiology

Shahid Husain, Canada, FECMM

15:15

S07.4 Side-effects and completion rates of universal versus targeted antifungal prophylaxis among lung transplant recipients 2010-2019

Cornelia Geisler Crone, Denmark

15:30

S07.5 Risk factors for and outcomes of invasive aspergillosis following kidney transplantation in the United States

Daniel Friedman, USA

Symposium 8 Update on diagnosis and treatment of chronic pulmonary aspergillosis (CPA)

Chairs: Aleksandra Barac, Serbia, FECMM & David Denning, United Kingdom, FECMM

14:15

S08.1 Diagnostic Value of Galactomannan in Bronchoalveolar Lavage Fluid for Chronic Respiratory Disease with Pulmonary Aspergillosis

Aleksandra Barac, Serbia, FECMM

14:35

S08.2 Underlying Conditions and Clinical Spectrum of Chronic Pulmonary Aspergillosis (CPA)

Eva Van Braeckel, Belgium

14:55

S08.3 Prevalence of chronic pulmonary aspergillosis in patients with tuberculosis

Felix Bongomin, Uganda, FECMM

15:15

S08.4 Prevalence of chronic pulmonary aspergillosis among active pulmonary tuberculosis patients with persisting symptoms in Uganda

Martha Namusobya, Uganda

15:30

S08.5 CPAepi: a study to investigate epidemiological characteristics of Aspergillus spp. isolated from CPA patients

Juan Carlos Soto Debran, Spain

Symposium 9 Latest results of ECMM and international registries

Chairs: Tamas Papp, Hungary, FECMM & Nathalie Friberg, Finland

14:15

S09.1 Distribution and Antifungal Susceptibility of yeasts causing invasive fungal diseases in China: An Update From the CHIF-NET Study

Yao Wang, China

14:30

S09.2 A global team effort - FungiScope

Danila Seidel, Germany, FECMM

14:45

S09.3 FUNGINOS – The Fungal Infection Network of Switzerland

Nina Khanna, Switzerland

15:00

S09.4 Update from ECMM and international registries: FungiScope Candida / CandiReg

Philipp Köhler, Germany, FECMM

15:15

S09.5 Epidemiology of Candida glabrata resistance in France and Germany within the frame of the ARest consortium

Alexandre Alanio, France, FECMM

15:30

S09.6 CPAnet: an International Chronic Pulmonary Aspergillosis Registry

Eva Van Braeckel, Belgium

15:45

Coffee break

16:15

Parallel Symposia 10-13

Symposium 10 Candida and other yeast infections

Chairs: Malcolm Richardson, United Kingdom, FECMM & Cornelia Lass-Flörl, Austria, FECMM

16:15

S10.1 Diagnosis of Candida: Culture, Beta-glucan and Mannan

Liz Johnson, United Kingdom, FECMM

16:35

S10.2 The role of PCR and T2 MR

Cornelia Lass-Flörl, Austria, FECMM

16:55

S10.3 Mixed Yeast infections - Common or not?

Ana Alastruey-Izquierdo, Spain, FECMM

17:15

S10.4 Epidemiology and Clinical Burden of Candida infections across Europe - Results of ECMM Candida III

Martin Hoenigl, Austria, FECMM & Maiken Arendrup, Denmark

Symposium 11 The Myc(icr)obiome and Fungal Infections

Chairs: Anne Puel, France & Ilse Jacobsen, Germany

16:15

S11.1 The Lung mycobiom in health and disease

Paul Bowyer, United Kingdom

16:35

S11.2. Epidemiology of Fungal Infection in the ICU: Viral Infection a relevant risk factor?

Matteo Bassetti, Italy

16:55

S11.3 Mycobiome and invasive candidiasis

Tobias Hohl, USA, FECMM

17:15

S11.4 Mycobiome and microbial interactions

Ilse Jacobsen, Germany

17:25

S11.5 Development of a novel mycobiome diagnostic for fungal infection

Danielle Weaver, United Kingdom

17:35

S11.6 Effect of exposition to broad-spectrum antibiotics on the gut mycobiota of healthy volunteers

Margot Delavy, France

Symposium 12 Viral infections and fungal disease

Chairs: Monica Slavin, Australia & Anna Maria Tortorano, Italy

16:15

S12.1 Immunology

Frank van de Veerdonk, the Netherlands

16:35

S12.2 Definition, Diagnosis and Treatment of COVID-19 associated pulmonary aspergillosis - ECMM/ISHAM Consensus Guidance

Philipp Köhler, Germany, FECMM

16:55

S12.3 Covid associated mucormycosis'

Arunaloke Chakrabarti, India, FECMM

17:10

S12.4 Cytomegalovirus infection and invasive fungal disease

Monica Slavin, Australia

17:25

S12.5 ECMM CAPA Pulmonary aspergillosis in critically ill coronavirus disease 2019 patients– a multinational study

Juergen Prattes, Austria

17:35

S12.6 Immunological profiles of patients with influenza-associated pulmonary aspergillosis (IAPA)

Intan Dewi, the Netherlands

Symposium 13 Emerging issues in mycology

Chair: Anuradha Chowdhary, India, FECMM & Suzana Hadina, Croatia

16:15

S13.1 Emergomyces

Nelesh Govender, South Africa, FECMM

16:35

S13.2 Emerging rare yeasts in outbreaks

Anuradha Chowdhary, India, FECMM

16:55

S13.3 Tracing patterns of evolution and acquisition of drug resistant Aspergillus fumigatus infection from the environment using population genomics

Matthew Fisher, United Kingdom

17:05

S13.4 EHA Guideline on antifungal prophylaxis in adult acute myeloid leukemia treated with novel agents

Jannik Stemler, Germany

17:15

S13.5 Candida auris clinical isolates from patients with COVID-19 in Saint Petersburg, Russia : identification, antifungal susceptibility

Ellina Oganesyan, Russia

17:25

S13.6 Hyperendemic zoonotic sporotrichosis: Implementation of a public health assistance service for human sporotrichosis in southern Brazil

Vanice Poester, Brazil

18:00

Sponsored Integrated Symposium 3

More information on www.timm2021.org/sponsored-symposia

19:30

Sponsored reception